Directorate Change

RNS Number : 6246S

Eden Research plc

04 December 2012

 



4 December 2012

Eden Research Plc

("Eden" or "Company")

Appointment of director

Eden Research Plc(AIM: EDEN), the AIM listed agrochemical and encapsulation development company, is pleased to announce that it has appointed Tom Lupton as a non-executive director with immediate effect.

Mr Lupton, aged 56, graduated from Oxford University in 1978 in Agriculture and Forest Sciences. After an executive career in the development and management of agriculture and forestry related enterprises largely in Africa and Asia, Mr Lupton recently was responsible for running a highly visible Farm Project at Sissinghurst.

His previous directorships are as follows:

Camellia PLC	2002-2006
Commonwealth Development Corporation	1978-2002
Tanganyika Wattle Company (Tanzania)	1996-1996
Kilombero Valley Teak Company (Tanzania)	1996-1996
Sable Farming Company Limited (Malawi)	1993-1996
Shiselweni Forestry Company Limited (Swaziland)	1989-1993

There is no further information to be disclosed in accordance with paragraph (g) Schedule Two, Aim Rules for Companies

Sir Ben Gill, Chairman of Eden said, "We are very pleased to welcome Tom to the Board and we welcome his contribution as a non-executive Director. Tom's extensive experience in agriculture and forestry internationally will be invaluable as we continue to target global opportunities in the agrochemical sector for our encapsulation technology."

Enquiries:

Eden Research plc	www.edenresearch.com
Clive Newitt, Managing Director	Tel: [phone]
Alex Abrey, Chief Financial Officer
W H Ireland Limited	www.wh-ireland.co.uk
John Wakefield / Marc Davies	Tel: [phone]
Walbrook PR Ltd	Tel: [phone]
Paul McManus (Media Relations)	Mob: [phone] or [e-mail]
Paul Cornelius (Investor Relations)	Mob: [phone] or [e-mail]

Notes:

Eden has developed a terpene-based encapsulation technology which uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.

Terpenes are natural compounds which function as defence mechanisms in many plant groups and are released in response to infection, attack by pests, stress or mechanical injury. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

The next-generation encapsulation technology, licensed from University of Massachusetts Medical School ("UMMS") recently, provides significant additional benefits to the original system as it allows release to be controlled by environmental factors rather than relying solely upon the chemistry of the substances used. This means that there is more control over the timing of the release of the active compound being carried allowing for further reduction in chemicals applied whilst ensuring maximum effectiveness.

The UMMS license also significantly expands the potential use of the Eden technology in non-agricultural applications such as health and beauty, cosmetics and animal health.

For more information about Eden, please visit www.edenresearch.com

 

END

 

 

BOAQXLFBLLFEFBE